A
Ariceum Therapeutics
Biotech & Life Sciences · Berlin, Germany · Founded 2021
Targeted radiopharmaceuticals for hard-to-treat cancers MoreLess
Ariceum Therapeutics is a biotechnology company that is focused on developing innovative treatments for cancer and other diseases. The company is dedicated to finding new ways to fight cancer and other diseases by combining cutting-edge technology and modern medicine. They use a combination of advanced analytics, data science, and machine learning to develop new treatments.
Ariceum Therapeutics is different from other businesses in the same industry because of their use of advanced analytics, data science, and machine learning to develop new treatments. They use Google Analytics Cookies, other external services, Google Webfont Settings, Google Map Settings, Google reCaptcha Settings, Vimeo and Youtube video embeds to analyze and develop treatments.
Ariceum Therapeutics makes a profit by selling their treatments to medical professionals and healthcare organizations. They also generate revenue through grants and investments from investors.
The company is committed to providing innovative treatments that can improve the lives of patients and make a real difference in the fight against cancer and other diseases.
Company overview
Ariceum Therapeutics company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2021
- Headquarters
- Berlin, Germany
- Employees
- 23
- Open positions
- None listed
- Dealroom signal
- 27.9
- Investment activity
- 1 companies · latest Jun 2023
- Capital deployed
- —
- Preferred round
- ACQUISITION
Valuation & funding
Ariceum Therapeutics funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | Apr 2023 | $25M | $138M | Earlybird Venture Capital · Pureos Bioventures · Andera Partners | ↗ |
| SERIES AOther financing | Jun 2022 | $28M | $110M | EQT Life Sciences · HealthCap · EQT Group · Pureos Bioventures | ↗ |
Growth signals
Ariceum Therapeutics website traffic
Latest recorded traffic for Ariceum Therapeutics is 340 monthly website visits, up 30.8% over the last three months. Ariceum Therapeutics's team declined 34.3% over the past year.
Comparisons
Ariceum Therapeutics compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Capital deployed
Ariceum Therapeutics investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Talent graph
Ariceum Therapeutics's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Ariceum Therapeutics has talent and traffic
team presence
In the news
Latest news about Ariceum Therapeutics
Recent press, funding announcements, and product moves mentioning Ariceum Therapeutics — open to read from the original sources.
Market sentiment
What the market is saying about Ariceum Therapeutics
An AI-synthesized read of the highest-engagement posts about Ariceum Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ariceum Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.